|Diabetes Mellitus Treatment Study using Zopolrestat
A multicenter, double-blind, placebo-controlled, parallel-group study of the effects of Oral Zopolrestat in Normotensive, Type 1 Diabetics with incipient Nephropathy (Microalbuminuria).
Zopolrestat is a novel medication which interferes with protein glycosylation and may delay and prevent the onset of vascular complications in diabetes mellitus.
Criteria for Participation:
Participants must be between the ages of 18 and 45 with a diagnosis of type 1 diabetes for more than 5 years. Women of child-bearing potential must be practicing a medically-approved method of birth control.
Benefits and/or Compensation:
Persons who qualify will receive free physical examinations, laboratory tests, electrocardiograms, kidney function tests, a blood glucose meter and supplies, medical supervision and a stipend.